Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 25

1.

Evolution of endemism on a young tropical mountain.

Merckx VS, Hendriks KP, Beentjes KK, Mennes CB, Becking LE, Peijnenburg KT, Afendy A, Arumugam N, de Boer H, Biun A, Buang MM, Chen PP, Chung AY, Dow R, Feijen FA, Feijen H, Feijen-van Soest C, Geml J, Geurts R, Gravendeel B, Hovenkamp P, Imbun P, Ipor I, Janssens SB, JocquƩ M, Kappes H, Khoo E, Koomen P, Lens F, Majapun RJ, Morgado LN, Neupane S, Nieser N, Pereira JT, Rahman H, Sabran S, Sawang A, Schwallier RM, Shim PS, Smit H, Sol N, Spait M, Stech M, Stokvis F, Sugau JB, Suleiman M, Sumail S, Thomas DC, van Tol J, Tuh FY, Yahya BE, Nais J, Repin R, Lakim M, Schilthuizen M.

Nature. 2015 Aug 20;524(7565):347-50. doi: 10.1038/nature14949. Epub 2015 Aug 12.

PMID:
26266979
2.

Molecular signature of adipose tissue in patients with both non-alcoholic fatty liver disease (NAFLD) and polycystic ovarian syndrome (PCOS).

Baranova A, Tran TP, Afendy A, Wang L, Shamsaddini A, Mehta R, Chandhoke V, Birerdinc A, Younossi ZM.

J Transl Med. 2013 May 31;11:133. doi: 10.1186/1479-5876-11-133.

3.

Expression of genes for microRNA-processing enzymes is altered in advanced non-alcoholic fatty liver disease.

Sharma H, Estep M, Birerdinc A, Afendy A, Moazzez A, Elariny H, Goodman Z, Chandhoke V, Baranova A, Younossi ZM.

J Gastroenterol Hepatol. 2013 Aug;28(8):1410-5. doi: 10.1111/jgh.12268.

PMID:
23663110
4.

Expression of inflammation-related genes is altered in gastric tissue of patients with advanced stages of NAFLD.

Mehta R, Birerdinc A, Neupane A, Shamsaddini A, Afendy A, Elariny H, Chandhoke V, Baranova A, Younossi ZM.

Mediators Inflamm. 2013;2013:684237. doi: 10.1155/2013/684237. Epub 2013 Mar 30.

5.

Knowledge-based identification of soluble biomarkers: hepatic fibrosis in NAFLD as an example.

Page S, Birerdinc A, Estep M, Stepanova M, Afendy A, Petricoin E, Younossi Z, Chandhoke V, Baranova A.

PLoS One. 2013;8(2):e56009. doi: 10.1371/journal.pone.0056009. Epub 2013 Feb 6.

6.

Gene expression profiles associated with depression in patients with chronic hepatitis C (CH-C).

Birerdinc A, Afendy A, Stepanova M, Younossi I, Baranova A, Younossi ZM.

Brain Behav. 2012 Sep;2(5):525-31. doi: 10.1002/brb3.72. Epub 2012 Jul 6.

7.

Gene expression profiles associated with anaemia and ITPA genotypes in patients with chronic hepatitis C (CH-C).

Birerdinc A, Estep M, Afendy A, Stepanova M, Younossi I, Baranova A, Younossi ZM.

J Viral Hepat. 2012 Jun;19(6):414-22. doi: 10.1111/j.1365-2893.2011.01564.x. Epub 2011 Dec 7.

PMID:
22571903
8.

The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin.

Younossi ZM, Birerdinc A, Estep M, Stepanova M, Afendy A, Baranova A.

J Transl Med. 2012 Feb 7;10:25. doi: 10.1186/1479-5876-10-25.

9.

Protein pathway activation associated with sustained virologic response in patients with chronic hepatitis C treated with pegylated interferon (PEG-IFN) and ribavirin (RBV).

Younossi ZM, Limongi D, Stepanova M, Pierobon M, Afendy A, Mehta R, Baranova A, Liotta L, Petricoin E.

J Proteome Res. 2011 Feb 4;10(2):774-9. doi: 10.1021/pr100923u. Epub 2011 Jan 4.

PMID:
21204552
10.

Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS).

Hossain N, Stepanova M, Afendy A, Nader F, Younossi Y, Rafiq N, Goodman Z, Younossi ZM.

Scand J Gastroenterol. 2011 Apr;46(4):479-84. doi: 10.3109/00365521.2010.539251. Epub 2010 Nov 30.

PMID:
21114431
11.

A biomarker panel for non-alcoholic steatohepatitis (NASH) and NASH-related fibrosis.

Younossi ZM, Page S, Rafiq N, Birerdinc A, Stepanova M, Hossain N, Afendy A, Younoszai Z, Goodman Z, Baranova A.

Obes Surg. 2011 Apr;21(4):431-9. doi: 10.1007/s11695-010-0204-1.

PMID:
20532833
12.

Validation of endogenous reference genes for qRT-PCR analysis of human visceral adipose samples.

Mehta R, Birerdinc A, Hossain N, Afendy A, Chandhoke V, Younossi Z, Baranova A.

BMC Mol Biol. 2010 May 21;11:39. doi: 10.1186/1471-2199-11-39.

13.

Phosphoproteomic biomarkers predicting histologic nonalcoholic steatohepatitis and fibrosis.

Younossi ZM, Baranova A, Stepanova M, Page S, Calvert VS, Afendy A, Goodman Z, Chandhoke V, Liotta L, Petricoin E.

J Proteome Res. 2010 Jun 4;9(6):3218-24. doi: 10.1021/pr100069e.

PMID:
20441224
14.

Hepatic gene expression of Caucasian and African-American patients with obesity-related non-alcoholic fatty liver disease.

Stepanova M, Hossain N, Afendy A, Perry K, Goodman ZD, Baranova A, Younossi Z.

Obes Surg. 2010 May;20(5):640-50. doi: 10.1007/s11695-010-0078-2. Epub 2010 Jan 30.

PMID:
20119733
15.

Functional pathway analysis of genes associated with response to treatment for chronic hepatitis C.

Birerdinc A, Afendy A, Stepanova M, Younossi I, Manyam G, Baranova A, Younossi ZM.

J Viral Hepat. 2010 Oct;17(10):730-6. doi: 10.1111/j.1365-2893.2009.01235.x.

PMID:
20002302
16.

Hepatic stellate cell and myofibroblast-like cell gene expression in the explanted cirrhotic livers of patients undergoing liver transplantation.

Estep JM, O'Reilly L, Grant G, Piper J, Jonsson J, Afendy A, Chandhoke V, Younossi ZM.

Dig Dis Sci. 2010 Feb;55(2):496-504. doi: 10.1007/s10620-009-0919-9. Epub 2009 Aug 13.

PMID:
19680808
17.

Independent predictors of fibrosis in patients with nonalcoholic fatty liver disease.

Hossain N, Afendy A, Stepanova M, Nader F, Srishord M, Rafiq N, Goodman Z, Younossi Z.

Clin Gastroenterol Hepatol. 2009 Nov;7(11):1224-9, 1229.e1-2. doi: 10.1016/j.cgh.2009.06.007. Epub 2009 Jun 25.

PMID:
19559819
18.

Gene expression profile associated with superimposed non-alcoholic fatty liver disease and hepatic fibrosis in patients with chronic hepatitis C.

Younossi ZM, Afendy A, Stepanova M, Hossain N, Younossi I, Ankrah K, Gramlich T, Baranova A.

Liver Int. 2009 Oct;29(9):1403-12. doi: 10.1111/j.1478-3231.2009.02060.x. Epub 2009 Jun 3.

PMID:
19515216
19.

Predictors of health-related quality of life in patients with chronic liver disease.

Afendy A, Kallman JB, Stepanova M, Younoszai Z, Aquino RD, Bianchi G, Marchesini G, Younossi ZM.

Aliment Pharmacol Ther. 2009 Sep 1;30(5):469-76. doi: 10.1111/j.1365-2036.2009.04061.x. Epub 2009 Jun 9.

20.

Expression of cytokine signaling genes in morbidly obese patients with non-alcoholic steatohepatitis and hepatic fibrosis.

Estep JM, Baranova A, Hossain N, Elariny H, Ankrah K, Afendy A, Chandhoke V, Younossi ZM.

Obes Surg. 2009 May;19(5):617-24. doi: 10.1007/s11695-009-9814-x. Epub 2009 Mar 12.

PMID:
19280268
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk